Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10613524 | Journal of Controlled Release | 2005 | 9 Pages |
Abstract
Physical mixtures were prepared containing indomethacin and β-lactose and α-lactose-based excipients (Ludipress® and Cellactose®). The mixtures were compacted with the aid of ultrasound, obtaining tablets, which were milled and sieved. Granules thus obtained were examined by optical microscopy and differential scanning calorimetry. The intense yellow color of the granules and the absence of indomethacin peak in thermograms suggest important modifications of indomethacin physical state; the drug thus modified appears to be spread on the excipient particle surface as a thin film, giving a lustrous appearance. No influence of ultrasound was observed on phase transition concerning lactose; only loss of water was important under high energy ultrasound. Dissolution profiles suggest an increased release of the drug from the systems treated with ultrasound at high energy, with respect to a traditional compaction; while no difference could be evidenced among the three excipients that, however, appear all suitable for this ultrasound-aided direct compression process.
Keywords
Related Topics
Physical Sciences and Engineering
Materials Science
Biomaterials
Authors
Cristina Cavallari, Beatrice Albertini, Lorenzo Rodriguez, Antonio M. Rabasco, Adamo Fini,